• Research Officer

    Haolu Wang

Dr Wang is an NHMRC Early Career Fellow who joined the University of Queensland Diamantina Institute in 2017. He has been working in improving the treatment response of benign and malignant liver diseases for 9 years after receiving his MBBS degree in 2009. He was awarded his PhD in 2017 under the supervision of Profs Michael Roberts and Darrell Crawford. He submitted his PhD thesis “Real-time optical imaging of the liver: diagnosis and prediction of treatment response” only 2 years and 11 months after his enrolment, which is one of the fastest tracks for the University of Queensland.

In research, Dr Wang has published a total of 46 peer-reviewed articles (17 as first author and 2 as corresponding author) in high-quality journals (Theranostics. 2018; Stem Cells Transl Med. 2018; Am J Surg. 2013 and Ann Surg Oncol. 2013) with an h-index of 16 and 578 citations in the last 5 years. His major contributions have been an improved understanding of drug resistance of liver cancer (Stem Cells Dev. 2013; Oncol Rep. 2013), optimisation of cell therapy against liver diseases (Curr Protoc Stem Cell Biol. 2017; Sci Rep. 2016), and establishment of preclinical imaging platforms for liver diseases (Biosens Bioelectron. 2017; Sci Rep. 2017; Biomed Opt Express. 2015). He has attracted over $300,000 in competitive funding as CIA including NHMRC ECF (2018-2021), and Pilot Grant of Translational Australian Clinical Toxicology Program. Dr Wang has been an invited speaker at several national and international conferences, highlighting his reputation as a researcher on hepatology and pharmacology.

In teaching, Haolu has completed supervision for two Honours students. Currently, he supervises one UQ PhD student (Anastasia Brooks, in vitro models for liver diseases) as principal supervisor and co-supervises 3 UQ PhD students (Min Teoh, cancer vaccines for hepatocellular carcinoma; Da Zou, cell-free systems for the treatment of liver diseases and Khuram Shahzad, nanoparticle-liver interactions).

In service and engagement, Dr Wang has been an invited reviewer of manuscripts for journals in the discipline of pharmacology, oncology and surgery (e.g. Inflammopharmacology, World J Surg Oncol, and BMC Surg). He has reviewed grant applications for NHMRC and Great Ormond Street Hospital Charity, the UK’s largest charitable funder of medical research dedicated to paediatrics. Dr Wang has been a Committee Member of the Australian Society for Medical Research (2015-2017). He has also served as a lecturer of the Professional Development Program of Redcliffe Hospital (2016). He is the representative of Preclinical Imaging Facility users in Translational Research Institute (2015 – present).